The Future of Women’s Health: Insights From Bethany Corbin

Bethany Corbin: 0:00

The advertising bans on the policies that social media platforms have in place are well intentioned in terms of wanting to make sure right that inappropriate content isn't being displayed for people who don't want to see it or for minors. But it's interesting, right? Because if we look at the algorithms that are fielding these advertisements, we see that

Harsh Thakkar: 0:19

what's up everybody, this is Harsh from qualtivate.com. And you're listening to the life sciences 360 podcast. On this show, I chat with industry experts and thought leaders to learn about their stories, ideas and insights, and how their role helps bring new therapies to patients. Thanks for joining us. Let's dive in. All right, welcome to another episode of Life Sciences 360. My guest today is Bethany Corbin. She is the co founder of FEM innovation and managing partner and Attorney at Women's Health Innovation consulting. Welcome to the show. Bethany.

Bethany Corbin: 0:51

Thank you so much for having me.

Harsh Thakkar: 0:53

I want to start off by asking you, what's your backstory or personal story that fueled sort of the passion for championing women's health and getting into this field?

Bethany Corbin: 1:03

Yeah, it's interesting, because whenever I went to law school, because I am an attorney FemTech was not even coined at that point in time. So it wasn't as if I went into law school with this perfect plan of wanting to go into women's health care and be in the women's health industry. I actually started my legal career in financial services and litigation, so something totally different. And I absolutely hated it. And so like many people, I was starting to find ways in which I could pivot to something that I was more passionate about, I've always been passionate about health care, because my mom has been involved with the health care system with a chronic illness since I was eight. And I was actually her primary caregiver for a significant portion of my early life. And so I thought maybe there's a way that I can help to make the healthcare system better based on the experiences that I've had. So I went, I switched into healthcare law, I was working at big law in Washington, DC for a while, went and was a law professor. And that was really when I came across the term femtech, for the first time was around 2018. And I got really excited, really interested decided to go back into the practice of law. And then lo and behold, I had my own women's health issue very unexpectedly. And so having to navigate the women's health journey as a patient, instead of an attorney, and a caregiver was something that was completely different. And as I researched my condition, I learned that 80% of women will have fibroids at some point in their life. And so I asked, my doctor said, Great, Where's where's the pill for this? And she goes, No, no, we haven't had a lot of inventions and innovation in fibroids in more than 30 years, our standard treatment is still a hysterectomy. And so that just outraged me. And I thought, Okay, well, after I go through this, I really want to help more Women's Health founders get their products to life faster, because we need to innovate in this industry. And that's really where my passion came from.

Harsh Thakkar: 2:54

Yeah, it's it's so amazing. I talked to many people who are in life sciences. And there's nothing like being in that shoes of a patient, whether it's you or somebody in your family, like I know so many colleagues, who I worked with in companies that were developing therapies for cancer, but then their family or somebody in there that they know, ended up taking those treatments, and they saw firsthand the impact on their lives like that. There's nothing that replaces that. And I know many people in life sciences industry are fueled to wake up and go to work just because of that reason. So that's really amazing.

Bethany Corbin: 3:31

Yeah, no, that's absolutely right. And that's the thing, too, that we've seen in the FEM tech industry is so many of the founders are in this industry because of the personal experiences that they've had, and their desire to make sure that nobody else suffers the same way that they have. So I think that's really one of the unique things about FemTech is just all of the interconnected and personal stories. And it's very unfortunate that when you go to conferences or events with other FemTech founders, that is just the common theme, right? Everybody there really has a story.

Harsh Thakkar: 4:02

So you being in this field having a network of other people who are in this field of femtech and female health innovation? What is one of the lesser known facts in this in this industry or domain that you wish more people would would be aware of?

Bethany Corbin: 4:20

Yeah, it's a great question. There's actually a couple. So everyone was really aware of the fact that women are driving 80% of the consumer spending decisions with respect to health care, that's one of the most popular cited statistics. The problem, though, that a lot of people don't understand is, even though we're driving a large majority of spending, we actually don't have a system in which health care products can be advertised to women in an effective way. So now give you an example. There's actually right now, an FTC Federal Trade Commission investigation going on and complaint that has been filed about the advertising practices of Facebook and other social media companies, because all of these femtech products that are in the market, they cannot advertise to women on the proper social media channels because of the long standing conflation of women's health, with sexuality. And so oftentimes these advertisements are getting blocked or banned and accounts are getting taken offline. Because of these that the way in which Women's Health is being talked about and conflated with something that's inappropriate. And so you might see advertisements for erectile dysfunction, right, which are pretty explicit. And then you might see a women's health advertisement that talks about polycystic ovary syndrome, right, and just has actual statistics. And that advertisement gets blocked. And so that's something I think, is not being talked about enough in the women's health industry, we have so much power as consumers, we drive so much of the healthcare decision making. And yet we can't get the information that we need about the femtech products that are out there because of those advertising bans.

Harsh Thakkar: 6:01

Yeah, that's that's a great example. And it's just it's such a completely different era that we live in, where when I was growing up, advertisements was something that you only saw on television, but now basically, anyone with an audience or good enough following can host their events, they can commercial, put their advertisements on the internet, and everything with the e Commerce Industry and direct to consumer industry, booming in the past five or 10 years is just that there needs to be some sort of regulation or clear guidance of not only just for your domain, but I'm sure other industries, niche industries are also facing the same challenge.

Bethany Corbin: 6:43

Oh, absolutely. And whenever you think about it, the advertising bans on the policies that social media platforms have in place are well intentioned, in terms of wanting to make sure right, that inappropriate content isn't being displayed for people who don't want to see it or for minors, that it's interesting, right? Because if we look at the algorithms that are fielding these advertisements, we see that they are conflating all of women's health, with sexuality based on the trainings and the data that's been inputted into them. And so those algorithms haven't really evolved over time to make that distinction between appropriate women's health care and sexual pleasure or sex toys or things like that, for which we're constantly getting conflated with.

Harsh Thakkar: 7:25

So being being in this field, if you had to paint a picture of the current landscape of FEM tech, what are you seeing today? And then what what do you see happening in the next five or 10 years?

Bethany Corbin: 7:38

Yeah, so right now we've made tremendous growth since 2016 when femTech was first coined, femtech hit over the $1 billion funding mark in 2021. If we look at it in terms of projected statistics, we're expected to hit between $50 billion and $97 billion dollars in funding and what the industry is worth by 2030. That may be a little bit of a high projection, but we are we're on that trajectory, right. This is something that we're seeing a lot of interest in investment in women's health care. In terms of the landscape right now we've got about 2000 FEM tech companies globally, about 2000 investors globally. A couple of 100 of innovation hubs and communities online for women to talk about their women's health concerns. And so that has grown substantially over the last couple of years. What we still see in FEM tech right now, is a lot of the products are focused on a couple of distinct areas. The first is reproductive health. I would say that's kind of where the main innovation is occurring in women's health care right now, for the FemTech industry and reproductive health, including periods, ovulation, fertility, maternal health care, those have been some of the key drivers historically, what we're also seeing, though, is a shift and a movement away from conflating women's health with reproductive health, and a desire to invest in more chronic care solutions, and long term illnesses that impact women or impact women differently than men. So some of the ones that have come on the market, we've seen menopause really take off since 2022. That's kind of been where a lot of the money's focused right now. We've also started to see investment in chronic care conditions. So things like trying to come up with diagnostic tools for ovarian cancer or breast cancer, those have been really front of mind. And whenever we think about some of the newer innovations, the other thing that really dominates the FEM tech landscape is the types of products that we have on the market. So right now, more than 52% of the products on the market are things that are considered right software, wearables or applications. And so that's where a lot of the innovation has happened. I'm a firm believer that going forward in the next five to 10 years, we need to push past those types of products into the more substantial and transformative innovations for women's health care. And what I mean by that is right now a lot of the software and apps and wearables that are on the market are not being scrutinized by the FDA or drug administration, because they're low risk to consumers. And so they're usually falling under FDA enforcement discretion. And we've also seen that investors are more likely to invest in those types of products right now, because they can get to market faster, and they can get their return on investment. And so what I really want to see in the next five to 10 years is a movement away from just the the quick one time app fixes into something that can say, this is how we're going to substantially fix cardiac cardiovascular disease for women. Here's a new, exciting test for finding ovarian cancer in the early stages. And those take time, those take clinical trials. But I think that's where the more meaningful innovation will happen. And I think we're getting there slowly, but it's taking it's taking some time. So that's where I'd like to see us go.

Harsh Thakkar: 10:51

Yeah, that's a very optimistic view. And I'm sure that a lot of the FEM tech founders and entrepreneurs who are taking that road of going through regulatory submission, that's one of the big drivers that takes so long, such a long time to go from identifying what your product is, and to getting the regulatory approval. I know some companies, life science companies spend decades trying to just go through that journey. So it's definitely requires a lot of patience and drive to, to go through that long journey and have people on your team that also willing to go to that?

Bethany Corbin: 11:30

Oh, absolutely. Yeah. And the other thing that's a little bit unique about FEMTech too, right is that it is focused on women's healthcare. And so whenever we think about getting the funding that's needed for the clinical trials, and the longer life cycle of more meaningful innovations coming onto the market, that's something where we also struggle with because a lot of the venture capital firms that are supplying money in the healthcare industry are male dominated, and they're less likely to fund a women's health company. And so that funding discrepancy is also part of the reason I think that it's taking us longer to get into more of the clinical trials and clinical science backgrounds that we need for the women's health industry.

Harsh Thakkar: 12:12

Yeah, yeah. And I hope that this episode, and this discussion spreads more awareness, understanding your story and passion and others like you in this field, we're also championing for this cause. So yeah, that's really great. And I want to talk about like, being in the consulting role, you said, you mentioned, you're an attorney. So when you were talking to clients, or other FEM tech founders, entrepreneurs who are hiring you for help, what are some of the challenges that they bring to you for help?

Bethany Corbin: 12:43

Yeah, there's a couple of different challenges that I see very commonly, and, and part of it does depend on what type of product that they're building. Right now, I will say one of the key areas that I get asked to consult on is data privacy. And I do have a lot more femtech companies, investors, and consumers are really focused on how their data is going to be protected in these femtech applications. And I would be lying if I said, right, femtech hasn't been affected by the dobs decision. It absolutely has. We live right now in an environment in which women are Miss trusting the technology that we're saying it's gonna change their lives. And so right now, I think that FEM Tech has a lot to do in terms of building back that trust. And so that's what a lot of FEM tech companies come to me for. And they say, what should we be building in our products at the outset, to make sure that we are enhancing consumer privacy and consumer trust. And so I do a lot of advising on that we talk about whether or not an app or a company is going to be regulated by HIPAA, whether or not it's something that will need to comply with GDPR if they're taking a more international approach, and kind of building in privacy and security by design principles. So that's kind of the first key area that I get asked about almost daily. The second key area I get asked about is really a lot more on the business strategy side rather than the legal side with respect to how do we approach investment, as I mentioned, getting money for femtech founders is very difficult. It's even more difficult in the current environment, when we think about the fact that funding for health care overall and digital health is down, right. And then you have the added burden, right of having to go and pitch to male VCs who may not understand the importance of the products. And so in that landscape, I often get times I oftentimes get asked, how should we be building our investment strategy? Where should we be going? One of the conversations that I have a lot has to do with non dilutive funding and grants as alternative opportunities to venture capital investment. And so really helping founders get not only their strategy in place, but also their their document sets ready for investors to take a look at helping them determine their differentiators in the market. I think different differentiation is really one of the key factors that has come out of a lot of the conversations I've had with investors this year, is that they've got to start seeing something different than the current products on the market in order to make it worthwhile to invest in, so data privacy and investment are very frequently discussed topics that I see with founders.

Harsh Thakkar: 15:09

Yeah, and I've seen data privacy also in my world where I do consulting mostly on quality management and regulatory compliance projects for life science companies. And because I'm involved in a lot of system implementation projects, data privacy is always, always a big concern. And now, with artificial intelligence coming into the mix, there is a big concern with how do we create the boundaries? Or how do we create the fence for not introducing intentional bias or something into the AI? Because some of those around how can companies make sure that employees and everyone that has access to this data understands the importance? Yes, having a having a policy or a procedure doesn't always work, you have to have more boots on the ground awareness. So any strategies of how clients do that in your field?

Bethany Corbin: 16:07

Yeah, it's a great question, I find that that oftentimes, it's got to be something that is starts from the top down. Because if your C suite, right, your board of directors aren't buying into the notion of privacy, then that just sets the tone for the entire company to have a more relaxed view of data privacy, we see this oftentimes in the structure and the culture of the company. And whether or not that culture is focused more on providing a solution for consumers versus monetizing the application or the device that they've created. Oftentimes, for companies that are more focused on getting to market quickly and making money, we find that they tend to have more relaxed privacy protocols, and less of a culture of compliance. When it comes to privacy. They're also the companies that are typically going to be more likely to sell or monetize the women's health data. So typically, I find that it starts at the top and kind of what is the CEO or the President's viewpoint on data privacy, if it is a very pro patient centric or pro patient privacy perspective, I find that that often trickles down not only in the policies that we see, but also in the commitment to training and education of the remaining workforce. And I think that's something that's absolutely vital. We see a couple of companies take different approaches, right some will do mandatory training on data privacy through onboarding, and then annual retraining. But some of the more privacy conscious companies are actually doing monthly trainings on data privacy, because things are changing rapidly. But there's also so many different ways in which privacy can be implemented or privacy can also be breached. And so making sure that they're staying ahead auditing and doing their monitoring and internal system controls as well, to make sure that role based access controls are in place and being adhered to. Those are some of the the key functions that we see in companies that take a very proactive stance on privacy. And I will also say in the FemTech industry, since this has become a key concern post Dobbs. We've also seen some companies dabble in, okay, how do we anonymize our applications? Right? Or can we put together anonymous nodes for our customers and consumers? And so I see a lot of confusion with companies around anonymization. I see companies trying to do the right thing, but then potentially misleading consumers as there's no standardized definition or protocols for anonymization yet, so I see companies moving in the right direction. And I think there's still kind of a fine line to lock between what they're able to implement and how that's conveyed to consumers as well.

Harsh Thakkar: 18:39

Yeah, like you mentioned, it has to happen from the top down. And if the management is not bought into this, any other strategy or external help from consultants, whatever it is, doesn't really work if they're not bought into this idea that this is something they need to do for, for their business operations or progress. I want to jump into like, the stuff that you're doing with your advocacy and community engagement initiatives. So can you I was researching and I read your experience about testifying before the Maryland cybersecurity Council. Can you just explain what was that? And how do you think, what were the implications of that on women's health?

Bethany Corbin: 19:23

Yeah, so I had the honor of testifying before the Maryland cybersecurity Council's ad hoc committee, and this was relatively soon after the Dobbs decision came out last year as a couple of months later. And what Maryland was trying to decide was really what data protection and cybersecurity protections should they put in place for women's health data, given the fact that now reproductive data has the potential to be used against women to prosecute abortion. And so that was really one of the key concerns and they invited several of us with different backgrounds and expertise to come and talk about kind of the history of data privacy in women's health and what we were seeing on the ground. And it was very powerful to be able to talk about and bring into that conversation, the FemTech industry, because not only are we talking about women's health data, right, that's being used by their providers. And I think that was that was a key portion of the discussion. But we also had to consider the non HIPAA applications of health data out there. Because that's where a lot of FEM tech companies fall into. And so it was, it was wonderful to be able to bring that aspect and say, great, you're talking about how can we protect healthcare data when it's in the provider setting, but here's also how we should be thinking about it when we think about femtech applications and other settings that aren't as heavily regulated under federal and state laws. So that was, that was a wonderful opportunity to get out there and get our voices heard about how we should be protecting women. And that they've, they're working on legislation following that discussion. And it really just underscores the need for for all of us to make our voices heard. There have been some significant advancements in reproductive health legislation across different states, I think California just signed into effect some more telemedicine abortion protections as well. And so kind of being on the ground as one of those advocates is, is a phenomenal experience. But also seeing the work that my colleagues are doing in those same spaces, and how they're making their own voices heard as well. I think it's very powerful.

Harsh Thakkar: 21:22

Yeah, and and I know, you've been asked this question before you've done your part, right? You've, you've participated in this, and you're a big advocate, and you're doing your community engagement initiatives. But what more projects or initiatives would you want to see from different states or different communities in this area? Like, what is it that you would like to see more of, towards community engagement?

Bethany Corbin: 21:47

Yeah, that's a fantastic question. Uh, one of the things that's really top of mind for me, and also that I'm working with a couple of Policy Advocates on building is I want to see more communication and collaboration between regulators, especially the FDA and the FTC, and HHS, and the FEM tech community. Because I think that with these public private partnerships, we have a huge potential to work with regulators and get regulation in the areas where it's most needed, rather than having regulation imposed from the top down on our industry in ways that might not be practical or feasible, but also in ways that may not further all of the different goals of the stakeholders in this industry. So I'm really working to create a women's Digital Health Coalition comprised of key stakeholders who want to get before these regulatory bodies, and want to be able to say, this is what we're seeing on the ground. Here's how we think regulation should should happen, or here are the areas we think are ripe for regulation. And here's how we think it can work practically speaking, given the realities of the FEM tech industry at this time, because one of the things you don't want to do. And of course, this is always a concern in any industry that's innovative, is you don't want to stifle that innovation and that entrepreneurship. And so I think finding that right balance through public private partnerships can really advance all parties interests. So that's something I think we really need to start bridging that gap. And getting that out there.

Harsh Thakkar: 23:15

And have you seen any, like any collapse, so that's something you want more of to happen. But have you seen any other interesting partnerships or collaborations, whether it's between companies, or whether it's between company and regulatory body? Have you seen any of those partnerships or collaborations happening towards a specific cause in this women's health innovation sector?

Bethany Corbin: 23:42

Yeah, I think that we've seen some really interesting company collaborations in this space. And that's also something that I think we're gonna see a lot more of going into the future because FEM tech right now is a very siloed industry in terms of somebody might be doing a period tracking app here an ovulation app here, a PCLs application or community here. And so we don't have a lot of cohesion. And I think one of the things that we're moving towards, and we're going to have to do in order to survive is collaboration and coming together, right, and having several products under one umbrella or one platform. And we've started to see some movement in that direction. One of my favorite ones that has just happened recently, actually is the oura ring. Does a lot of the Start familiars a lot of the fitness tracking general health tracking similar to the Apple Watch, they've actually just entered into a partnership with natural cycles, which is the first FDA approved kind of non hormonal birth control. And so it's interesting because natural cycles, is able to get all of this data right about women's health, but prior to its partnership with oura ring, female users of oura ring, we're having to manually input similar data. And now it can seamlessly connect in a way that can provide some substantial insights into women's health that I that both companies could not do on their own. And that's what they've realized. started to see or has really started to see this partnership and more of their users are kind of coming back online re adopting the technology because of that partnership with natural cycles. And that then gives us enhanced data sets. Because right now, we don't have datasets on women's health that are clinically meaningful to the extent that we do for men's health. And so what we're seeing now is these partnerships can produce clinically meaningful data and wide amounts of data that could then be used downstream in order to influence and understand women's health. And that's another key partnership area that we have started to see is these FemTech companies partnering with research institutions to give their data downstream in order for that data to influence long term women's health care.

Harsh Thakkar: 25:48

Yeah, it's it's very important, and just your journey of everything that you you've delved into in your career and your story that you started off this episode with. So I want to ask you this about just entrepreneurship. In general, you are doing a lot of projects, you've got a lot of accomplishments on your career profile. What What were some of the highs and lows in your journey? If you were to share with like, somebody that's 10 years behind you following the same path?

Bethany Corbin: 26:23

Wow, what a question. Um, I think I think some of the highs are when you work with the companies that are making meaningful products and innovations in this space, and you're able to help them and you see their journey and how it's progressed, because of the advice. And the documents that you've given and created for them. That has been just one of one of the key moments is watching those companies grow and get to market and seeing the customers reaction to those products and being able to say what I worked with that company, or I know that company, and I'm so proud of where they are today because of that. So that has definitely been one of one of the highs. In terms of lows, I think there's always the pressure to do more and to feel like you haven't done enough, I definitely feel that even today at this stage of entrepreneurship. But I would also say, one of the lows is is knowing that you have to take risks. So for me, launching into this entrepreneurial journey, I had to leave my job at big law where I had a substantial salary, I had comfort, I had a job, I knew how to do very well, I was next in line for a partner. And to say what this is, this is the journey that I need to go on because of my experiences now. And to leave all of that behind and know that you're taking a substantial salary cut, at least initially, is very nerve wracking. There are times in which you you sit there and you wonder whether or not you've done the right thing, right, you have your breakdown moments we all do. And and it's really interesting, because you have to see, okay, that didn't work, let me now I've got a pivot. And so that's, I think one of the the hardest challenge of entrepreneurship is really that initial leap that you have to make, it's oftentimes exciting, but also very nerve wracking and very emotional. And it does work out I have to say, from my experience, and the experiences that I have seen others goes through is it does work out. And a lot of people are much happier for having taken that jump in that journey. And the other thing is not everyone will agree with what you're doing. Not everyone will have positive things to say I've been lucky that the FEM tech community is so supportive. But I have definitely run into my share of people who don't have kind things to say right or don't believe in the power of this industry. And so I think that's kind of another low that you have to learn how to navigate the different feedback that you're getting, find what's meaningful, make changes if they're appropriate, but also learn how to filter out the noise.

Harsh Thakkar: 28:50

Yeah, definitely. Yeah, I, I've 100% agree with you the ability to adapt, because entrepreneurship is always there's highs and lows in months, in years and in days, right? You have to know how to go through each of those. And that's one of the things I've learned in the last two years since I started my entrepreneurship journey. But I'm still learning I'm not perfect, but it's definitely something to it's a challenging piece of, of being in this

Bethany Corbin: 29:18

It absolutely is. And I think to what also is field. difficult is that sometimes we oftentimes we don't see the behind the scenes of somebody else's entrepreneurship journey, right? We see that highlight reel on social media, or wherever they are today. And we just assumed Wow, they got there that must have been easy for them. And so whenever we encounter those struggles on our own entrepreneurship journey, we can feel down right, we can feel depressed about what's happening. And we don't realize that every other entrepreneur has gone through this exact same thing. You just haven't seen it. So for instance, one of the lows was whenever I first started out on my own, I created a legal course that I thought would be a great offering for FEM tech companies. I was like, great. I've got this 10 week course, it should be very, very attractive to companies. Nobody signed up, right? Not one, zero people signed up. And I thought, wow, this is this is a very bad deflating moment, right? Because I had built something, I poured a lot of energy into it, I thought it was going to be a market need. And it just the fit just wasn't there. And so that's something right that a lot of people don't know, they never saw kind of what happened, they saw the public facing announcements for it. And then they never know, okay, did that succeed? Or did that fail? So we all have those types of opportunities and those types of failures and is taking that right and learning to pivot and you say, Okay, maybe people don't want a 10 week legal course. Maybe they want a 10 week course that includes product development, partnership opportunities, marketing advice, right, you take that you transform it you pivot, and then you are able to kind of relaunch and go back out with maybe what's a more successful product?

Harsh Thakkar: 30:55

Yeah, yeah, definitely. With social media, I think most of the times, the aspects of being an entrepreneur that are highlighted are mostly the highs, or the end goals of what somebody achieved. But I do like following a lot of entrepreneurs and creators and thought leaders who are actually sharing behind the scenes, right, they're being vulnerable. They're, they're sharing their lows and giving a sneak peek into what it really means. Because it's right 90% of the people think, Oh, this is just easy, you get to be your own boss. But it's it's not. It's never that it's never that easy.

Bethany Corbin: 31:35

Never is.

Harsh Thakkar: 31:38

Yeah, but the power of On the plus side, having social media having an incredible network of people, I'm sure you have a network of your go to people in your industry, once you get that, and it, you build on that every month, every year it compounds. And then whenever you need help, it's always there for you. Nobody takes it away from you. So that's, I think, the best part of social media.

Bethany Corbin: 32:04

I've been a follower of yours for the last couple of years, or I see you everywhere. And then you sit there and you think, Oh, I don't feel like I'm everywhere. I don't feel like I'm on social media, or I'm at all these conferences, because I only see the ones that I didn't get right, I only see what more I could be doing, versus seeing the impact and the inspiration that I'm having on other people. So sometimes you just don't have that other insight. And you have this tendency to feel like you always have to do more. And it's sometimes nice to get that feedback from other people and kind of how they're perceiving the work you're doing. And to take a step back and say, you know, what I what I have accomplished to date is great, yeah, here's where I want to go in the next five years. But don't forget to take time to kind of recognize where you are right now in your journey, and how far you've come just in the last six months or a year.

Harsh Thakkar: 32:58

Yeah, thanks. This has been a really amazing episode, because it's there's so much different content and different topics that I normally don't discuss with guests. And I'm so glad that you accepted the request to come on the show, I'm sure the audience are going to also find something refreshing and unique in this episode with what you're doing. your passion, your energy is contagious, and keep doing what you're doing. For the audience who's listening in to this episode? Where can they connect with you learn more about you? I know you're also writing a book, if you want to give a shout out to that, where can people get in touch with you?

Bethany Corbin: 33:34

Absolutely. So I'm very active on LinkedIn, it's linkedin.com/in/bethanycorbin, you can also find us at FEM innovation.com. And my personal website is Bethany corbin.com. I am working with the American Health Law Association on getting out the first book that focuses on healthcare innovation, and really what both founders and attorneys need to know to build successful careers and companies in this space. So working with some co authors on that very excited for that book should be out hopefully in 2024.

Harsh Thakkar: 34:07

Wow, that's huge. And much needed. Yeah, and any final thoughts before we wrap this up? I really don't. I have. I'm just so thankful that you you came to the show and you shared everything that you did.

Bethany Corbin: 34:21

Well, thank you so much for having me. The one last piece of advice I will leave people with is if you can do one thing each day that furthers your your passion, right your career where you would like to be in a year or two. Do that one thing from me. I said what if I could connect with one person or if I could make one LinkedIn posts that will get me towards my goal. It took me five minutes each day. And as a result, I was able to become a thought leader in women's health in under a year. So just think of how powerful time of that one thing that you can do is and go from there.

Harsh Thakkar: 34:55

Yep, that's that's very useful advice. I can I tell you that I've done it for the last 365 days and it does work, but you have to do it for a year at least before you see any results.

Bethany Corbin: 35:10

Absolutely.

Harsh Thakkar: 35:11

Yeah, Thank you so much, Bethany. I wish you a great week ahead and rooting for everything that you're doing all the projects, rooting for you from the sidelines. Thank you. Thank you so much for listening. I hope you enjoyed today's episode. Check out the show notes in the description for a full episode summary with all the important links. Share this with a friend on social media and leave us a review on Apple podcast, Spotify or wherever you listen to your favorite podcast.